Organoids have revolutionized science and medicine, providing platforms for disease modeling, drug testing, and understanding developmental processes. While not exact replicas of human organs, they ...

Each day, a human adult loses on average 50 to 70 billion cells, which die from natural causes alone. New cells replace lost ...

Leveraging the power of AI and machine learning technologies, researchers developed a more effective model for predicting how patients with muscle-invasive bladder cancer will respond to chemotherapy.

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

Researchers at the University of Michigan and University of Minnesota find women often lack sufficient information about general bladder health.

In March 2025, Merck Sharp & Dohme LLC announced a study are to learn if people who receive V940 and pembrolizumab are alive ...

The company’s Phase I trial found that patients remained disease free after three months utilising the lowest doses of RAG-01 ...

Investigators employed artificial intelligence to characterize tissue samples of high-risk NMIBC that were likely to recur or progress after treatment with intravesical bacillus Calmette-Guérin (BCG).

(NEXSTAR) – New cases of a dangerous, drug-resistant fungus have been identified in at least two states’ hospital systems. Candida auris, also called C. auris, was first identified in the U.S ...

Reusable Incontinence Products Market The reusable incontinence products market is set to grow from USD 5.8 Bn in 2025 to USD 8.3 Bn by 203 ...

China's AI race is heating up, with new models making waves in the industry. One new contender is Manus, an AI agent being hailed as the next potential "DeepSeek moment." Here are five key players ...